Literature DB >> 12857987

The role of t/b lymphocyte collaboration in the regulation of autoimmune and alloimmune responses.

Hooman Noorchashm1, Siri A Greeley, Ali Naji.   

Abstract

The present review highlights the two areas of research pursuit in our laboratory: (1). the regulation of the autoimmune T cell response to pancreatic islet beta cells using the nonobese diabetic (NOD) mouse model of type 1 diabetes and (2). the regulation the T cell response to alloantigens. Our work has established a central role for B lymphocytes in driving both autoimmune and allo-immmune T cell responses. Our studies indicate that: (1). B cell-deficient NOD mice are protected from autoimmune diabetes; (2). targeted disruption of cognate T/B cell collaboration via major histocompatibility complex (MHC) class II prevents both T cell-mediated islet destruction and allograft rejection; and (3). maternal transmission of islet-reactive autoantibodies potentiates the activation of diabetogenic T cells, highlighting the important role of B cells in the early targeting of islet beta cells.

Entities:  

Mesh:

Year:  2003        PMID: 12857987     DOI: 10.1385/IR:27:2-3:443

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  21 in total

1.  I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.

Authors:  H Noorchashm; Y K Lieu; N Noorchashm; S Y Rostami; S A Greeley; A Schlachterman; H K Song; L E Noto; A M Jevnikar; C F Barker; A Naji
Journal:  J Immunol       Date:  1999-07-15       Impact factor: 5.422

2.  Impaired activation of islet-reactive CD4 T cells in pancreatic lymph nodes of B cell-deficient nonobese diabetic mice.

Authors:  S A Greeley; D J Moore; H Noorchashm; L E Noto; S Y Rostami; A Schlachterman; H K Song; B Koeberlein; C F Barker; A Naji
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

3.  An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes.

Authors:  E P Reich; R S Sherwin; O Kanagawa; C A Janeway
Journal:  Nature       Date:  1989-09-28       Impact factor: 49.962

4.  Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice.

Authors:  Siri Atma W Greeley; Makoto Katsumata; Liping Yu; George S Eisenbarth; Daniel J Moore; Heidi Goodarzi; Clyde F Barker; Ali Naji; Hooman Noorchashm
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

5.  Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice.

Authors:  T Akashi; S Nagafuchi; K Anzai; S Kondo; D Kitamura; S Wakana; J Ono; M Kikuchi; Y Niho; T Watanabe
Journal:  Int Immunol       Date:  1997-08       Impact factor: 4.823

6.  Impaired CD4 T cell activation due to reliance upon B cell-mediated costimulation in nonobese diabetic (NOD) mice.

Authors:  H Noorchashm; D J Moore; L E Noto; N Noorchashm; A J Reed; A L Reed; H K Song; R Mozaffari; A M Jevnikar; C F Barker; A Naji
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

7.  Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.

Authors:  D L Kaufman; M Clare-Salzler; J Tian; T Forsthuber; G S Ting; P Robinson; M A Atkinson; E E Sercarz; A J Tobin; P V Lehmann
Journal:  Nature       Date:  1993-11-04       Impact factor: 49.962

8.  Monoclonal T cells identified in early NOD islet infiltrates.

Authors:  Y Yang; B Charlton; A Shimada; R Dal Canto; C G Fathman
Journal:  Immunity       Date:  1996-02       Impact factor: 31.745

9.  B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo.

Authors:  S Constant; N Schweitzer; J West; P Ranney; K Bottomly
Journal:  J Immunol       Date:  1995-10-15       Impact factor: 5.422

10.  T cell receptor V gene usage of islet beta cell-reactive T cells is not restricted in non-obese diabetic mice.

Authors:  N Nakano; H Kikutani; H Nishimoto; T Kishimoto
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more
  4 in total

1.  Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys.

Authors:  Shahrooz S Kelishadi; Agnes M Azimzadeh; Tianshu Zhang; Tiffany Stoddard; Emily Welty; Christopher Avon; Mitch Higuchi; Amal Laaris; Xiang-Fei Cheng; Christine McMahon; Richard N Pierson
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

2.  Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunity.

Authors:  Maki Nakayama; Joshua N Beilke; Jean M Jasinski; Masakazu Kobayashi; Dongmei Miao; Marcella Li; Marilyne G Coulombe; Edwin Liu; John F Elliott; Ronald G Gill; George S Eisenbarth
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

3.  Long-term control of alloreactive B cell responses by the suppression of T cell help.

Authors:  Yijin Li; Lianli Ma; Dengping Yin; JiKun Shen; Anita S Chong
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

4.  Preemptive CD20+ B cell Depletion Attenuates Cardiac Allograft Vasculopathy in CD154-Treated Monkeys.

Authors:  Agnes M Azimzadeh; Tianshu Zhang; Guosheng Wu; Shahrooz S Kelishadi; Tiffany Stoddard; Natalie OʼNeill; Bao-Ngoc Nguyen; Emily Welty; Christopher Avon; Mitch Higuchi; Stuart L Mitchell; Alena Hershfeld; Xiang-Fei Cheng; Anthony Kronfli; Elana Rybak; Lars Burdorf; Richard N Pierson
Journal:  Transplantation       Date:  2017-01       Impact factor: 4.939

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.